Safety and Efficacy of Rivaroxaban When Added to Aspirin Monotherapy Among Stabilized Post‐Acute Coronary Syndrome Patients: A Pooled Analysis Study of ATLAS ACS‐TIMI 46 and ATLAS ACS 2‐TIMI 51
Journal of the American Heart Association - United Kingdom
doi 10.1161/jaha.118.009451
Full Text
Open PDFAbstract
Available in full text
Date
March 5, 2019
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)